Among the MRT xenografts studied, all but RBD1 were deficient in SMARCB1 at both protein and RNA levels, with five out of six models showing objective tumor responses (one maintained complete response (MCR), two complete responses (CRs), and two partial responses (PRs)). The gene discussed is SMARCB1; the disease is neoplasm.